The DOI matches its Crossref record; 112 of the 115 references it cites were found in a registry or an index.
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Open accessAbstract
One-fourth of all deaths in industrialized countries result from coronary heart disease. A century of research has revealed the essential causative agent: cholesterol-carrying low-density lipoprotein (LDL). LDL is controlled by specific receptors (LDLRs) in liver that remove it from blood. Mutations that eliminate LDLRs raise LDL and cause heart attacks in childhood, whereas mutations that raise LDLRs reduce LDL and diminish heart attacks. If we are to eliminate coronary disease, lowering LDL should be the primary goal. Effective means to achieve this goal are currently available. The key questions are: who to treat, when to treat, and how long to treat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The receptors for LDL (LDLR) and transferrin receptor (TFR) are both endocytosed from the cell surface via clathrin-coated vesicles and transported through intracellular recycling pathways (14, 15, 16, 17, 18, 19, 20).”
From The small GTPase RAB10 regulates endosomal recycling of the LDL receptor and transferrin receptor in hepatocytes (2022) · cites this paper as [14]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“LDLR plays a crucial role in the uptake of LDL-C from the circulation by hepatocytes 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The regulation of LDLR trafficking and turnover is essential for maintaining cholesterol homeostasis and remains a major focus of therapeutic strategies for CVD 1,2,7 .”
From Dietary cholesterol activates a Ral-dependent pathway driving LDLR turnover (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Elevated LDL-C levels are linked to an increased risk of ASCVD,4,5”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [5]
In the citing paper
“Unlike common diseases, the clarity of causation for Mendelian disorders usually simplifies the task of generating models (including human cells and organoids or rodents) to connect genotype to organismal phenotype; these have led to many critical insights into the biology of health and disease in humans98,99.”
From A brief history of human disease genetics (2020) · cites this paper as [98]
In the citing paper
“These data suggest that lifelong lower levels of plasma LDL cholesterol are much more effective than late LDL reductions induced by statins in preventing coronary heart disease (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“Hypercholesterolemia is one of the key risk factors in promoting atherosclerosis, which is the underlying cause of approximately 90% of cases of myocardial infarction, 60% of strokes, most cases of chronic heart failure, peripheral arterial disease, and vascular dementia (31).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [31]
In the citing paper
“An example is the J-shaped association between alcohol consumption and cardiovascular disease; there is now consensus that this apparent protective effect of moderate levels of consumption is artefactual, as discussed above.130”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“For example, a large-effect genetic variant influencing alcohol consumption that has been of considerable value in MR studies of the effects of alcohol75,130 is only prevalent in East Asian populations.”
From Mendelian randomization (2022) · cites this paper as [130]
In the citing paper
“Mutations in LDLR cause familial hypercholesterolemia (FH), characterized by elevated levels of plasma LDL-C and increased risk of coronary heart disease (1).”
From Identification of amino acid residues in the MT-loop of MT1-MMP critical for its ability to cleave low-density lipoprotein receptor (2022) · cites this paper as [1]
In the citing paper
“Statins block cholesterol synthesis by suppressing HMG-CoA reductase91”
From EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Self-citation(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Self-citationSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Self-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citation
Flagged first, then by citations
3 of the 115 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Anitschkow, 1913, Ueber experimentelle cholesterinsteatose und ihre bedeutung für die entstehung einiger pathologischer prozesse, Zentralbl. Allg. Pathol. Anat., 24, 1
- Goldstein, 1982, Lipoprotein receptors: Genetic defense against atherosclerosis, Clin. Res., 30, 417
Cited by
Sorted by citations
Items 301–400 of 1,000
The multifaceted therapeutic value of targeting ATP-citrate lyase in atherosclerosis
Verberk, S. G. S., Kuiper, K. L., Lauterbach, M., Latz, E., & den Bossche, J. V. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.09.004 · Cited by 37
Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
Xiao, X., Luo, Y., & Peng, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.879355 · Cited by 66
Butyrate Lowers Cellular Cholesterol through HDAC Inhibition and Impaired SREBP-2 Signalling
Bridgeman, S. C., Woo, H. C., Newsholme, P., & Mamotte, C. D. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415506 · Cited by 41
Dyslipidemias in clinical practice
Cabezas, M. C., Burggraaf, B., & Klop, B. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.09.010 · Cited by 36
Wibæk, R., Vistisen, D., Girma, T., Admassu, B., Abera, M., Abdissa, A., Jørgensen, M. E., Kæstel, P., Michaelsen, K. F., Friis, H., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002888 · Cited by 35
Orekhov, A. N., Nikiforov, N. G., Sukhorukov, V. N., Kubekina, M. V., Sobenin, I. A., Wu, W., Foxx, K. K., Pintus, S. S., Stegmaier, P., Stelmashenko, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030817 · Cited by 35
The emerging landscape of peptide-based inhibitors of PCSK9
Tombling, B. J., Zhang, Y., Huang, Y., Craik, D. J., & Wang, C. K. L. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.903 · Cited by 34
2022 Taiwan lipid guidelines for primary prevention
Huang, P., Lu, Y., Tsai, Y., Wu, Y., Li, H., Chang, H.-Y., Wu, C., Yang, C., Tarng, D., Huang, C., et al. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.05.010 · Cited by 37
Targeting ApoC-III to Reduce Coronary Disease Risk
Khetarpal, S. A., Qamar, A., Millar, J. S., & Rader, D. J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0609-y · Cited by 34
microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism
Ru, P., & Guo, D. (2017) · RNA & DISEASE · doi:10.14800/rd.1525 · Cited by 34
Liu, C., Zhu, J., Hai, B., Zhang, W., Wang, H., Leng, H., Xu, Y., & Song, C. (2019) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000006502 · Cited by 34
White, J. B., Trim, P. J., Salagaras, T., Long, A., Psaltis, P. J., Verjans, J. W. H., & Snel, M. F. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03770 · Cited by 34
Detection and Real-Time Monitoring of LDL-Cholesterol by Redox-Free Impedimetric Biosensors
Assaifan, A. K., Alqahtani, F. A., Alnamlah, S., Almutairi, R., & Alkhammash, H. I. (2022) · BioChip Journal · doi:10.1007/s13206-022-00058-z · Cited by 34
Nutrient sensing of mTORC1 signaling in cancer and aging
Jiang, C., Tan, X., Liu, N., Yan, P., Hou, T., & Wei, W. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.08.001 · Cited by 35
Data gaps limit the translational potential of preclinical research
Kleiman, R. J., & Ehlers, M. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9888 · Cited by 33
Hussain, S. S., Harris, M. T., Kreutzberger, A. J. B., Inouye, C. M., Doyle, C. A., Castle, A. M., Arvan, P., & Castle, J. D. (2018) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-08-0519 · Cited by 34
Ye, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.012669 · Cited by 32
Kober, D. L., Xu, S., Li, S., Bajaj, B., Liang, G., Rosenbaum, D. M., & Radhakrishnan, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2018578117 · Cited by 33
Zuo, Y., Zhang, C., Zhou, Y., Li, H., Xiao, W., Herzog, R. W., Xu, J., Zhang, J., Chen, Y. E., & Han, R. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01036-0 · Cited by 33
Tumor-derived factors affecting immune cells
Russo, V. E. A., & Protti, M. P. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.06.005 · Cited by 33
Genome-scale CRISPR screening for modifiers of cellular LDL uptake
Emmer, B. T., Sherman, E. J., Lascuna, P. J., Graham, S. E., Willer, C. J., & Ginsburg, D. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009285 · Cited by 32
Zhang, M., Gong, W., Zhang, D., Ji, M. H., Chen, B., Chen, B., Li, X., Zhou, Y., Dong, C., Wen, G., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04858-x · Cited by 35
Catar, R. A., Chen, L., Zhao, H., Wu, D., Kamhieh‐Milz, J., Lücht, C., Zickler, D., Krug, A. W., Ziegler, C. G., Morawietz, H., et al. (2022) · Cells · doi:10.3390/cells11020204 · Cited by 32
Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol
Tao, W., Moore, R., Meng, Y., Smith, E. R., & Xu, X.-X. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063065 · Cited by 32
Christensen, J. J., Arnesen, E., Rundblad, A., Telle‐Hansen, V. H., Narverud, I., Blomhoff, R., Bogsrud, M. P., Retterstøl, K., Ulven, S. M., & Holven, K. B. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117433 · Cited by 31
SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance
Wei, G., Huang, Y., Li, W., Xie, Y., Zhang, D., Niu, Y., & Zhao, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02354-7 · Cited by 37
Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics
Lum, K. M., Sato, Y., Beyer, B. A., Plaisted, W. C., Anglin, J. L., Lairson, L. L., & Cravatt, B. F. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00581 · Cited by 31
PAH exposure is associated with enhanced risk for pediatric dyslipidemia through serum SOD reduction
Wang, Q., Xu, X., Zeng, Z., Hylkema, M. N., Cai, Z., & Huo, X. (2020) · Environment International · doi:10.1016/j.envint.2020.106132 · Cited by 32
Palazón‐Bru, A., Hernández-Lozano, D., & Gil-Guillén, V. F. (2020) · Sports Medicine · doi:10.1007/s40279-020-01364-y · Cited by 30
Hsu, C., Zhao, J., Lin, S., Shyue, S., Guo, B., Lu, T., & Lee, T. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003327 · Cited by 30
ASTLEY, S. B., & Finglas, P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.03425-9 · Cited by 30
Chen, L. W., Lin, C., Tsai, M., Shih, S.-F., Lim, Z. W., Chen, S., Tsui, P.-F., Ho, L., Lai, J., & Liou, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143534 · Cited by 29
Germ-Free Swiss Webster Mice on a High-Fat Diet Develop Obesity, Hyperglycemia, and Dyslipidemia
Logan, I. E., Bobe, G., Miranda, C. L., Vasquez‐Perez, S., Choi, J., Lowry, M. B., Sharpton, T. J., Morgun, A., Maier, C. S., Stevens, J. F., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8040520 · Cited by 31
Hao, Y., Xiong, R., & Gong, X. (2020) · Inflammation · doi:10.1007/s10753-020-01365-z · Cited by 32
Cybulska, B., Kłosiewicz−Latoszek, L., Penson, P. E., Nabavi, S. M., Lavie, C. J., & Banach, M. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.12.008 · Cited by 30
Jalaja, R., Shyni, G. L., Mohan, S., Nair, M. S., Gopalan, R. K., & Somappa, S. B. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104664 · Cited by 30
Membrane-type I matrix metalloproteinase (MT1-MMP), lipid metabolism and therapeutic implications.
Xia, X.-D., Alabi, A., Wang, M., Gu, H.-M., Yang, R. Z., Wang, G.-Q., & Zhang, D.-W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab048 · Cited by 29
Structural advances in sterol-sensing domain-containing proteins
Wu, X., Yan, R., Cao, P., Qian, H., & Yan, N. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2021.12.005 · Cited by 31
Sakai, K., Nagashima, S., Wakabayashi, T., Tumenbayar, B., Hayakawa, H., Hayakawa, M., Karasawa, T., Ohashi, K., Yamazaki, H., Takei, A., et al. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311664 · Cited by 30
Causal Effect of Lipids and Lipoproteins on Atherosclerosis
Ference, B. A. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.001 · Cited by 28
The Inseparable Relationship Between Cholesterol and Hedgehog Signaling
Siebold, C., & Rohatgi, R. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-040313 · Cited by 37
Liu, L., Aimaiti, X., Zheng, Y.-Y., Zhi, X.-Y., Wang, Z.-L., Yin, X., Pan, Y.-B., Wu, T.-T., & Xie, X. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01876-2 · Cited by 34
Chen, Z., Zhou, R., Liu, X., Wang, J., Wang, L., Lv, Y., & Yu, L. (2025) · Life · doi:10.3390/life15020166 · Cited by 35
Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells
Sola‐Leyva, A., Lopez-Cara, L. C., Ríos‐Marco, P., Ríos, A., Marco, C., & Carrasco-Jimenez, M. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-40885-z · Cited by 29
Singhal, A., Krystofiak, E., Jerome, W. G., & Song, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65627-4 · Cited by 32
Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism
Guo, S., Xia, X.-D., Gu, H.-M., & Zhang, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_9 · Cited by 30
Krüppel-like factor 14 deletion in myeloid cells accelerates atherosclerotic lesion development
Wang, H. H., Guo, Y., Lu, H., Luo, Y., Hu, W., Liang, W., Garcia-Barrio, M. T., Chang, L., Schwendeman, A. A., Zhang, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab027 · Cited by 29
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Lee, H. A., Chang, Y. W., Sung, P. S., Yoon, E. L., Lee, H. W., Yoo, J., Lee, Y., An, J., Song, D. S., Cho, Y. Y., et al. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0186 · Cited by 31
Protein glycation in diabetes mellitus
Shin, A., Connolly, S. M., & Kabytaev, K. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.003 · Cited by 34
Larsen, S. V., Holven, K. B., Ottestad, I. O., Dagsland, K. N., Myhrstad, M. C. W., & Ulven, S. M. (2018) · Genes & Nutrition · doi:10.1186/s12263-018-0600-z · Cited by 28
KLF5 governs sphingolipid metabolism and barrier function of the skinPreprint
Lyu, Y., Guan, Y., Deliu, L. P., Humphrey, E., Frontera, J. K., Yang, Y. J., Zamler, D. B., Kim, K. H., Mohanty, V., Jin, K., et al. (2022) · Genes & Development · doi:10.1101/gad.349662.122 · Cited by 30
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis
Ma, F., Longo, M., Meroni, M., Bhattacharya, D., Paolini, E., Mughal, S., Hussain, S., Anand, S. K., Gupta, N., Zhu, Y., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.020 · Cited by 29
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology
Marcuzzi, A., Piscianz, E., Zweyer, M., Bortul, R., Loganes, C., Girardelli, M., Baj, G., Monasta, L., & Celeghini, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030365 · Cited by 27
Churuangsuk, C., Lean, M. E. J., & Combet, E. (2020) · Proceedings of The Nutrition Society · doi:10.1017/s0029665120000105 · Cited by 31
Dubey, V., Bozorg, B., Wüstner, D., & Khandelia, H. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007554 · Cited by 27
A multienzyme S-nitrosylation cascade regulates cholesterol homeostasis
Stomberski, C. T., Venetos, N. M., Zhou, H., Qian, Z., Collison, B., Field, S. J., Premont, R. T., & Stamler, J. S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111538 · Cited by 27
Cholesterol trafficking, lysosomal function, and atherosclerosis
Skeyni, A., Pradignac, A., Matz, R. L., Terrand, J., & Boucher, P. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00415.2023 · Cited by 30
Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
Jing, H., Reed, A., Ulanovskaya, O. A., Grigoleit, J.-S., Herbst, D. M., Henry, C. L., Li, H., Barbas, S., Germain, J., Masuda, K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112971118 · Cited by 24
Statins as Repurposed Drugs in Gynecological Cancer: A Review
Wang, K., Liu, C., & Ding, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213937 · Cited by 27
An endothelial SOX18–mevalonate pathway axis enables repurposing of statins for infantile hemangioma
Holm, A., Graus, M. S., Wylie‐Sears, J., Tan, J. W. H., Alvarez-Harmon, M., Borgelt, L., Nasim, S., Chung, L. H., Jain, A., Sun, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci179782 · Cited by 27
Cannet, C., Pilotto, A., Rocha, J. C., Schäfer, H., Spraul, M., Berg, D., Nawroth, P. P., Kasperk, C. H., Gramer, G., Haas, D., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-1329-5 · Cited by 27
Genetics of Alzheimer’s disease
König, T., & Stögmann, E. (2021) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00819-9 · Cited by 31
Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management
Waiz, M., Alvi, S. S., & Khan, M. S. (2021) · EXCLI journal · doi:10.17179/excli2021-4453 · Cited by 30
Therapeutic PCSK9 targeting: Inside versus outside the hepatocyte?
Corsini, A., Ginsberg, H. N., & Chapman, M. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108812 · Cited by 27
The Chemical Potential of Plasma Membrane Cholesterol: Implications for Cell Biology
Ayuyan, A. G., & Cohen, F. S. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.12.042 · Cited by 26
IDOL regulates systemic energy balance through control of neuronal VLDLR expression
Lee, S. D., Priest, C., Bjursell, M., Gao, J., Arneson, D. V., Ahn, I. S., Diamante, G., van Veen, J. E., Massa, M. G., Calkin, A. C., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0127-7 · Cited by 26
Geng, J., Xu, H., Fu, W., Yu, X., Xu, G., Cao, H., Lin, G., & Sui, D. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8733 · Cited by 26
Recent advances in regulating cholesterol and bile acid metabolism
Sato, R. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1793658 · Cited by 27
Blocking cholesterol storage to treat Alzheimer's disease
Chang, T. Y., Chang, C. C. Y., Harned, T. C., De La Torre, A. L., Lee, J., Huynh, T. N., & Gow, J. G. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00014 · Cited by 28
Kumrić, M., Urlić, H., Božić, J., Vilović, M., Kurir, T. T., Glavaš, D., Miric, D., Zanchi, J., Bradarić, A., Lozo, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098062 · Cited by 27
Reprint of: Impact of Lipids on Cardiovascular Health
Ference, B. A., Graham, I. M., Tokgözoğlu, L. S., & Catapano, A. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.021 · Cited by 26
Beyond Calories: An Integrated Approach to Promote Health, Longevity, and Well-Being
Bertozzi, B., Tosti, V., & Fontana, L. (2017) · Gerontology · doi:10.1159/000446346 · Cited by 25
The mevalonate pathway in breast cancer biology
Göbel, A., Riffel, R. M., Hofbauer, L. C., & Rachner, T. D. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215761 · Cited by 25
Zaborowska, M., Broniatowski, M., Wydro, P., Matyszewska, D., & Bilewicz, R. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113570 · Cited by 27
Zhao, C., Zuckerman, S. T., Cai, C., Kilari, S., Singh, A. K., Simeon, M. L., von Recum, H. A., Korley, J. N., & Misra, S. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018418 · Cited by 25
Chua, Y.-A., Razman, A. Z., Ramli, A. S., Kasim, N. A. M., & Nawawi, H. M. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.57026 · Cited by 25
Chatzopoulou, F. M., Kyritsis, K., Papagiannopoulos, C. I., Galatou, E., Mittas, N., Theodoroula, N. F., Papazoglou, Α. S., Karagiannidis, E., Chatzidimitriou, M., Papa, A., et al. (2022) · Cells · doi:10.3390/cells11040607 · Cited by 26
Cold shock domain-containing protein E1 is a posttranscriptional regulator of the LDL receptor
Smith, G. A., Padmanabhan, A., Lau, B. H., Pampana, A., Li, L., Lee, C. Y., Pelonero, A., Nishino, T., Sadagopan, N., Xia, V. Q., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj8670 · Cited by 23
The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions
Maxfield, F. R., Steinfeld, N., & Ma, C.-I. J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1148304 · Cited by 27
Ma, M., Hou, C. J., & Liu, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1148486 · Cited by 26
Membrane cholesterol as regulator of human rhomboid protease RHBDL4.
Paschkowsky, S., Recinto, S. J., Young, J. C., Bondar, A.-N., & Munter, L. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002640 · Cited by 29
Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
Kim, G., & Kang, E. S. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679956 · Cited by 25
Lee, M.-F., Chiang, C.-H., Lin, S., Song, P.-P., Liu, H.-C., Wu, T., & Lin, W. (2020) · BioMed Research International · doi:10.1155/2020/3495682 · Cited by 26
Kale, D., Fatangare, A., Phapale, P. B., & Sickmann, A. (2023) · Cells · doi:10.3390/cells12242796 · Cited by 24
Current pharmacotherapeutic options for primary dyslipidemia in adults
Cicero, A. F. G., Landolfo, M., Ventura, F., & Borghi, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1604687 · Cited by 24
Valsdottir, T. D., Henriksen, C., Odden, N., Nellemann, B., Jeppesen, P. B., Hisdal, J., Westerberg, A. C., & Jensen, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01499 · Cited by 26
Sandoval-Ramírez, B. A., Catalán, Ú., Calderón-Pérez, L., Companys, J., Pla‐Pagà, L., Ludwig, I. A., Romero, M., & Solà, R. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1709801 · Cited by 25
Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
Bakeberg, M. C., Gorecki, A. M., Kenna, J. E., Jefferson, A., Byrnes, M. L., Ghosh, S., Horne, M. K., McGregor, S., Stell, R., Walters, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.656623 · Cited by 25
The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study
Squier, K., Scott, A., Hunt, M. A., Brunham, L. R., Wilson, D. R., Screen, H. R. C., & Waugh, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257269 · Cited by 24
Mulugeta, A., Hyppönen, E., Ala‐Korpela, M., & Mäkinen, V. (2022) · Scientific Reports · doi:10.1038/s41598-022-12198-1 · Cited by 26
Shen, Y., Gu, H.-M., Zhai, L., Wang, B., Qin, S., & Zhang, D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159196 · Cited by 24
Houttu, V., Grefhorst, A., Cohn, D. M., Levels, J. H. M., van Lennep, J. E. R., Stroes, E. S. G., Groen, A. K., & Tromp, T. R. (2023) · Nutrients · doi:10.3390/nu15040962 · Cited by 25
Xu, S., Ge, Y., Wang, X., Yin, W., Zhu, X., Wang, J., & Qiao, S. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2186319 · Cited by 24
The Roles of SUMO in Metabolic Regulation
Kamynina, E., & Stover, P. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_9 · Cited by 25
Butler, A. A., Price, C. A., Graham, J. L., Stanhope, K. L., King, S. M., Hung, Y.-H., Sethupathy, P., Wong, S. C., Hamilton, J., Krauss, R. M., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m089508 · Cited by 25
Lin, M., Wang, Z., Wang, D., Chen, X., & Zhang, J. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.8b05337 · Cited by 24
Ahmad, P., Alvi, S. S., & Khan, M. S. (2019) · Springer eBooks · doi:10.1007/978-981-13-7154-7_20 · Cited by 24
Hober, A., Edfors, F., Ryaboshapkina, M., Malmqvist, J., Rosengren, L., Percy, A. J., Lind, L., Forsström, B., Uhlén, M., Oscarsson, J., et al. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra119.001765 · Cited by 26
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Wu, Y., Song, W., Su, M., He, J., Hu, R., & Zhao, Y. (2025) · Cancer Medicine · doi:10.1002/cam4.70783 · Cited by 23
Nakashima, Y., Miyagi‐Shiohira, C., Noguchi, H., & Ōmasa, T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.06.005 · Cited by 24
Metadata
- Authors
- Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Goldstein, Joseph L.
- Brown, Michael S.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 161
- Issue
- 1
- Pages
- 161-172
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4525717
- OpenAlex
- W2160347316
- Cited by
- 1,233
- References
- 115
- Citations by year
- 2026: 101 · 2025: 134 · 2024: 117 · 2023: 121 · 2022: 136 · 2021: 150 · 2020: 116 · 2019: 105 · 2018: 87 · 2017: 84 · 2016: 61 · 2015: 19
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Regeneron Pharmaceuticals
- National Heart, Lung, and Blood Institute (HL-20948, P01HL020948)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- cholesterol, coronary artery disease, low-density lipoprotein, LDL receptor, LDLR mutations, familial hypercholesterolemia, statins, lipid-lowering therapy, atherosclerosis
- MeSH terms
- Animals, Cardiovascular Diseases, Cholesterol, Coronary Vessels, Dietary Fats, Humans, Receptors, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Plaque, Atherosclerotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
